- Home
- CSTM vs VRDN Comparison
CSTM vs VRDN Comparison
Compare CSTM & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTM
- VRDN
- Stock Information
- Founded
- CSTM 2010
- VRDN 2006
- Country
- CSTM France
- VRDN United States
- Employees
- CSTM N/A
- VRDN N/A
- Industry
- CSTM Metal Fabrications
- VRDN Medical Specialities
- Sector
- CSTM Industrials
- VRDN Health Care
- Exchange
- CSTM Nasdaq
- VRDN Nasdaq
- Market Cap
- CSTM 1.2B
- VRDN 1.3B
- IPO Year
- CSTM 2013
- VRDN N/A
- Fundamental
- Price
- CSTM $13.38
- VRDN $14.49
- Analyst Decision
- CSTM Buy
- VRDN Strong Buy
- Analyst Count
- CSTM 3
- VRDN 11
- Target Price
- CSTM $18.00
- VRDN $38.50
- AVG Volume (30 Days)
- CSTM 1.6M
- VRDN 718.6K
- Earning Date
- CSTM 07-22-2025
- VRDN 08-07-2025
- Dividend Yield
- CSTM N/A
- VRDN N/A
- EPS Growth
- CSTM N/A
- VRDN N/A
- EPS
- CSTM 0.50
- VRDN N/A
- Revenue
- CSTM $7,434,000,000.00
- VRDN $302,000.00
- Revenue This Year
- CSTM $3.76
- VRDN N/A
- Revenue Next Year
- CSTM $12.00
- VRDN $17,102.33
- P/E Ratio
- CSTM $26.93
- VRDN N/A
- Revenue Growth
- CSTM N/A
- VRDN 4.86
- 52 Week Low
- CSTM $7.33
- VRDN $9.90
- 52 Week High
- CSTM $19.65
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- CSTM 61.70
- VRDN 50.32
- Support Level
- CSTM $12.97
- VRDN $14.11
- Resistance Level
- CSTM $13.36
- VRDN $16.05
- Average True Range (ATR)
- CSTM 0.45
- VRDN 0.74
- MACD
- CSTM -0.10
- VRDN -0.13
- Stochastic Oscillator
- CSTM 62.98
- VRDN 20.18
About CSTM Constellium SE (France)
Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).